Randomized sequential hormonal therapy vs adrenalectomy for metastatic breast carcinoma

Area of Science:

• Oncology
• Endocrinology

Background:

• Metastatic breast carcinoma presents a significant challenge in treatment selection.
• Sequential hormonal manipulation is a standard approach, but its efficacy can be limited.

Purpose of the Study:

• To evaluate adrenalectomy as a primary therapy versus sequential hormonal manipulation for metastatic breast carcinoma.
• To compare response rates and survival times in postmenopausal and premenopausal women.

Main Methods:

• A randomized study involving 226 patients (161 postmenopausal, 65 premenopausal) with metastatic breast carcinoma.
• Postmenopausal patients were randomized to primary hormone therapy followed by adrenalectomy, or primary adrenalectomy followed by chemotherapy/hormone therapy.
• Premenopausal patients were randomized to oophorectomy then adrenalectomy, or primary adrenalectomy-oophorectomy.

Main Results:

• Primary adrenalectomy demonstrated a significantly higher response rate (38.6%) compared to sequential therapy (20%) in postmenopausal women.
• Premenopausal women also showed a higher response rate with primary adrenalectomy-oophorectomy (41.9%) versus sequential oophorectomy and adrenalectomy (17.4%).
• No significant difference in survival time was observed between primary adrenalectomy and sequential hormonal manipulation groups in either postmenopausal or premenopausal patients.

Conclusions:

• Primary adrenalectomy offers a superior response rate for metastatic breast carcinoma in both postmenopausal and premenopausal women.
• While survival times are comparable, primary adrenalectomy may be a more effective initial treatment strategy.
• Adrenalectomy as a secondary procedure yielded lower response rates but comparable survival, suggesting its utility in later stages.